Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01745120
Brief Title: A Study Evaluating the Safety and Efficacy of the LentiGlobin BB305 Drug Product in β-Thalassemia Major Participants

First Submitted : December 6, 2012
First Submitted that Met QC Criteria : December 6, 2012
First Posted : December 7, 2012 (Estimate)

Results First Submitted : February 7, 2019
Results First Submitted that Met QC Criteria : April 16, 2019
Results First Posted : May 8, 2019

Last Update Submitted that Met QC Criteria : April 16, 2019
Last Update Posted : May 8, 2019